CD274 and neoplasm: A study examined 290 tumor tissues of HR+ and HER2+ breast cancers, TNBC, and MpBC for immunohistochemical staining of PD-1 on tumor-infiltrating lymphocytes (TILs) and PD-L1 in breast cancer cells [34].